APP and amyloidosis: APP/PS1 mice co-express human mutant amyloid precursor protein (APP) and presenilin-1 (PS1), leading to increased production of Aβ (particularly Aβ42), early plaque formation, neuroinflammation, and cognitive deficits, making them a robust model for amyloid pathology.